Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
6,171
datasets available to search
ShareScore release 0.9.0
Dataset results
6,171 results for “mutant”
A Multicentre, Retrospective-prospective Real-world Study: to Evaluate the Effectiveness and Safety of Vorasidenib in Patients With Isocitrate Dehydrogenase IDH1/2 Mutant Grade 2 Astrocytoma or Oligod
ClinicalTrials.gov study NCT06969352. IPD Sharing: NO. Countries: 1. Publications: 0.
Trametinib Plus Anlotinib Combined With Tislelizumab in KRAS-mutant NSCLC
ClinicalTrials.gov study NCT06456138. IPD Sharing: NO. Countries: 1. Publications: 0.
Phase I Study of Individualized Neoantigen Peptides in the Treatment of EGFR Mutant Non-small Cell Lung Cancer
ClinicalTrials.gov study NCT04397926. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of Palbociclib in Combination With Binimetinib for Patients With Advanced KRAS Mutant Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT03170206. IPD Sharing: NO. Countries: 1. Publications: 0.
Refametinib in Combination With Sorafenib in RAS Mutant Hepatocellular Carcinoma (HCC)
ClinicalTrials.gov study NCT01915602. IPD Sharing: Not stated. Countries: 21. Publications: 0.
Firmonertinib Combined With Definitive Radiotherapy in Stage III Unresectable EGFR Uncommon Mutant Pulmonary Adenocarcinoma
ClinicalTrials.gov study NCT07314216. IPD Sharing: NO. Countries: 1. Publications: 0.
Trial of IDH305 in IDH1 Mutant Grade II or III Glioma
ClinicalTrials.gov study NCT02977689. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Detection of Resistance Mechanisms in Cerebrospinal Fluid for EGFR-mutant, ALK- and ROS1-rearranged
ClinicalTrials.gov study NCT05116618. IPD Sharing: NO. Countries: 1. Publications: 0.
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
ClinicalTrials.gov study NCT06982521. IPD Sharing: Not stated. Countries: 10. Publications: 0.
ORIENT-31 Regimen in Combination with SBRT for EGFR-mutant Metastatic NSCLC After First-line Third-generation EGFR-TKIs
ClinicalTrials.gov study NCT06775743. IPD Sharing: Not stated. Countries: 0. Publications: 0.
(HARMONY) Study of BLU-701 in EGFR-mutant NSCLC
ClinicalTrials.gov study NCT05153408. IPD Sharing: NO. Countries: 1. Publications: 0.
Intracranial Genetically Modified Immune Cells (TGFβR2KO/IL13Rα2 CAR T-Cells) for the Treatment of Recurrent or Progressive Glioblastoma or Grade 3 or 4 IDH-Mutant Astrocytoma
ClinicalTrials.gov study NCT06815029. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study to Evaluate TNG348 Alone and With a PARP Inhibitor in Patients With BRCA 1/2 Mutant or HRD+ Solid Tumors
ClinicalTrials.gov study NCT06065059. IPD Sharing: NO. Countries: 1. Publications: 0.
Mutant KRAS -Targeted Long Peptide Vaccine for Patients at High Risk of Developing Pancreatic Cancer
ClinicalTrials.gov study NCT05013216. IPD Sharing: NO. Countries: 1. Publications: 0.
Safety and Efficacy of IB-FOLFIRI in BRAF V600E-Mutant Metastatic Colorectal Cancer
ClinicalTrials.gov study NCT07150247. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Efficacy of SRT as Salvage Therapy in Patients With Brain Oligo-progression of EGFR-mutant Non-small Cell Lung Cancer After Failure of the Third-generation EGFR-TKIs
ClinicalTrials.gov study NCT04519983. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Safety and Efficacy of Topical TolaSure Targeting Aggregated Mutant Keratin in Severe Epidermolysis Bullosa Simplex
ClinicalTrials.gov study NCT05062070. IPD Sharing: NO. Countries: 1. Publications: 0.
Study of RMC-5127 in Patients With Advanced KRAS G12V-Mutant Solid Tumors
ClinicalTrials.gov study NCT07349537. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of EGF816 in Combination With Selected Targeted Agents in EGFR-mutant NSCLC
ClinicalTrials.gov study NCT03333343. IPD Sharing: NO. Countries: 6. Publications: 0.
The Efficacy of Bevacizumab and Serplulimab Combined With Recombinant Mutant HumanTumor Necrosis Factor(rmhTNF-NC) in the Treatment of Malignant Ascites
ClinicalTrials.gov study NCT06433869. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.